The -607C/A Polymorphisms in Interleukin-18 Gene Promoter Contributes to Cancer Risk: Evidence from A Meta-Analysis of 22 Case-Control Studies

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Wang, Ming ^a   Zhu, Xiao Yang ^b   Wang, Liang ^a   Lin, Yu ^c  

^a CANGZHOU CENTRAL HOSPITAL   (China)

^b THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c AFFILIATED HOSPITAL OF INNER MONGOLIA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 18;

AFRICA; ARTICLE; ASIAN; CANCER RISK; CASE CONTROL STUDY; CAUCASIAN; ESOPHAGUS CANCER; ETHNICITY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; IL 18 GENE; NASOPHARYNX CARCINOMA; PROMOTER REGION; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW;

CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-18; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; REGRESSION ANALYSIS;

EID: 84885090206     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076915     Document Type: Article

References (42)

1. Bazan JF, Timans JC, Kastelein RA, (1996) A newly defined interleukin-1? Nature 379: 591. doi:10.1038/379591a0. PubMed: 8628393.
2. Dinarello CA, (1999) Interleukin-18. Methods 19: 121-132. doi:10.1006/meth.1999.0837. PubMed: 10525448.
3. Baxevanis CN, Gritzapis AD, Papamichail M, (2003) In vivo antitumor activity of NKT cells activated by the combination of IL-12 and IL-18. J Immunol 171: 2953-2959. PubMed: 12960319.
4. Lebel-Binay S, Berger A, Zinzindohoué F, Cugnenc P, Thiounn N, et al. (2000) Interleukin-18: biological properties and clinical implications. Eur Cytokine Netw 11: 15-26. PubMed: 10705295.
5. Tschoeke SK, Oberholzer A, Moldawer LL, (2006) Interleukin-18: a novel prognostic cytokine in bacteria-induced sepsis. Crit Care Med 34: 1225-1233. doi:10.1097/01.CCM.0000208356.05575.16. PubMed: 16540967.
6. Sims JE, (2002) IL-1 and IL-18 receptors, and their extended family. Curr Opin Immunol 14: 117-122. doi:10.1016/S0952-7915(01)00306-5. PubMed: 11790541.
7. Vidal-Vanaclocha F, Mendoza L, Telleria N, Salado C, Valcárcel M, et al. (2006) Clinical and experimental approaches to the pathophysiology of interleukin-18 in cancer progression. Cancer Metastasis Rev 25: 417-434. doi:10.1007/s10555-006-9013-3. PubMed: 17001512.
8. Tsuboi K, Miyazaki T, Nakajima M, Fukai Y, Masuda N, et al. (2004) Serum interleukin-12 and interleukin-18 levels as a tumor marker in patients with esophageal carcinoma. Cancer Lett 205: 207-214. doi:10.1016/j.canlet.2003.10.010. PubMed: 15036653.
9. Giedraitis V, He B, Huang WX, Hillert J, (2001) Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. J Neuroimmunol 112: 146-152. doi:10.1016/S0165-5728(00)00407-0. PubMed: 11108943.
10. Pratesi C, Bortolin MT, Bidoli E, Tedeschi R, Vaccher E, et al. (2006) Interleukin-10 and interleukin-18 promoter polymorphisms in an Italian cohort of patients with undifferentiated carcinoma of nasopharyngeal type. Cancer Immunol Immunother 55: 23-30. doi:10.1007/s00262-005-0688-z. PubMed: 16059673.
11. Farjadfar A, Mojtahedi Z, Ghayumi MA, Erfani N, Haghshenas MR, et al. (2009) Interleukin-18 promoter polymorphism is associated with lung cancer: a case-control study. Acta Oncol 48: 971-976. doi:10.1080/02841860902878145. PubMed: 19642044.
12. Taheri M, Hashemi M, Eskandari-Nasab E, Fazaeli A, Arababi F, et al. (2012) Association of-607 C/A polymorphism of IL-18 gene (rs1946518) with breast cancer risk in Zahedan, Southeast Iran. Prague Med Rep 113: 217-222. PubMed: 22980562.
13. Asefi V, Mojtahedi Z, Khademi B, Naeimi S, Ghaderi A, (2009) Head and neck squamous cell carcinoma is not associated with interleukin-18 promoter gene polymorphisms: a case-control study. J Laryngol Otol 123: 444-448. doi:10.1017/S0022215108003733. PubMed: 18940019.
14. Lau J, Ioannidis JP, Schmid CH, (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127: 820-826. doi:10.7326/0003-4819-127-9-199711010-00008. PubMed: 9382404.
15. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188. doi:10.1016/0197-2456(86)90046-2. PubMed: 3802833.
16. Higgins JP, Thompson SG, (2004) Controlling the risk of spurious findings from meta-regression. Stat Med 23: 1663-1682. doi:10.1002/sim.1752. PubMed: 15160401.
17. Begg CB, Mazumdar M, (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101. doi:10.2307/2533446. PubMed: 7786990.
18. Egger M, Davey Smith G, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634. doi:10.1136/bmj.315.7109.629. PubMed: 9310563.
19. Haghshenas MR, Hosseini SV, Mahmoudi M, Saberi-Firozi M, Farjadian S, et al. (2009) IL-18 serum level and IL-18 promoter gene polymorphism in Iranian patients with gastrointestinal cancers. J Gastroenterol Hepatol 24: 1119-1122. doi:10.1111/j.1440-1746.2009.05791.x. PubMed: 19638090.
20. Babar M, Ryan AW, Anderson LA, Segurado R, Turner G, et al. (2012) Genes of the interleukin-18 pathway are associated with susceptibility to Barrett's esophagus and esophageal adenocarcinoma. Am J Gastroenterol 107: 1331-1341. doi:10.1038/ajg.2012.134. PubMed: 22664470.
21. Du B, Zhao J, Wei Y, (2012) Interleukin-18 genegenetic polymorphisms and risk of nasopharyngeaI carcinomain in Han population from Sichuan China. Med. J West China 24: 1683-1685.
22. Farhat K, Hassen E, Bouzgarrou N, Gabbouj S, Bouaouina N, et al. (2008) Functional IL-18 promoter gene polymorphisms in Tunisian nasopharyngeal carcinoma patients. Cytokine 43: 132-137. doi:10.1016/j.cyto.2008.05.004. PubMed: 18555694.
23. Guo JY, Qin AQ, Li RK, Yang CM, Huang FD, et al. (2012) [Association of the IL-18 gene polymorphism with susceptibility to colorectal cancer]. Zhonghua Wei Chang Wai Ke Za Zhi 15: 400-403.
24. Kashef MA, Dehaghani AS, Naeimi S, Fattahi MJ, Ghaderi A, (2008) Interleukin-18 gene promoter polymorphisms in women with gestational trophoblastic diseases. J Reprod Med 53: 853-859. PubMed: 19097518.
25. Khalili-Azad T, Razmkhah M, Ghiam AF, Doroudchi M, Talei AR, et al. (2009) Association of interleukin-18 gene promoter polymorphisms with breast cancer. Neoplasma 56: 22-25. doi:10.4149/neo_2009_01_22. PubMed: 19152241.
26. Liu JM, Liu JN, Wei MT, He YZ, Zhou Y, et al. (2013) Effect of IL-18 gene promoter polymorphisms on prostate cancer occurrence and prognosis in Han Chinese population. Genet Mol Res 12: 820-829. doi:10.4238/2013.March.15.2. PubMed: 23546966.
27. Liu Y, Lin N, Huang L, Xu Q, Pang G, (2007) Genetic polymorphisms of the interleukin-18 gene and risk of prostate cancer. DNA Cell Biol 26: 613-618. doi:10.1089/dna.2007.0600. PubMed: 17688413.
28. Nikiteas N, Yannopoulos A, Chatzitheofylaktou A, Tsigris C, (2007) Heterozygosity for interleukin-18-607 A/C polymorphism is associated with risk for colorectal cancer. Anticancer Res 27: 3849-3853. PubMed: 18225542.
29. Nong LG, Luo B, Zhang L, Nong HB, (2009) Interleukin-18 gene promoter polymorphism and the risk of nasopharyngeal carcinoma in a Chinese population. DNA Cell Biol 28: 507-513. doi:10.1089/dna.2009.0912. PubMed: 19622039.
30. Qi T, Wang Q, Zheng L, Yang HL, Bao J, (2008) [Correlation of serum IL-18 level and IL-18 gene promoter polymorphisms to the risk of cervical cancer]. NAN Fang Yi Ke Xue Xue Bao 28: 754-757.
31. Sáenz-López P, Carretero R, Vazquez F, Martin J, Sánchez E, et al. (2010) Impact of interleukin-18 polymorphisms-607 and-137 on clinical characteristics of renal cell carcinoma patients. Hum Immunol 71: 309-313. doi:10.1016/j.humimm.2009.11.010. PubMed: 19961892.
32. Samsami Dehaghani A, Shahriary K, Kashef MA, Naeimi S, Fattahi MJ, et al. (2009) Interleukin-18 gene promoter and serum level in women with ovarian cancer. Mol Biol Rep 36: 2393-2397. doi:10.1007/s11033-009-9469-7. PubMed: 19263242.
33. Vairaktaris E, Serefoglou ZC, Yapijakis C, Agapi C, Vassiliou S, et al. (2007) The interleukin-18-607A/C polymorphism is not associated with risk for oral cancer. Anticancer Res 27: 4011-4014. PubMed: 18225563.
34. Wei YS, Lan Y, Liu YG, Tang H, Tang RG, et al. (2007) Interleukin-18 gene promoter polymorphisms and the risk of esophageal squamous cell carcinoma. Acta Oncol 46: 1090-1096. doi:10.1080/02841860701373595. PubMed: 17851835.
35. Yang HL, Pin BH, Wang Q, Zheng L, Tang W, et al. (2007) [Association of interleukin-18 gene rs1946519 and rs360718 single nucleotide polymorphism with cervical cancer]. Nan Fang Yi Ke Da Xue Xue Bao 27: 1006-1008.
36. Günel N, Coşkun U, Sancak B, Günel U, Hasdemir O, et al. (2002) Clinical importance of serum interleukin-18 and nitric oxide activities in breast carcinoma patients. Cancer 95: 663-667. doi:10.1002/cncr.10705. PubMed: 12209760.
37. Kawabata T, Ichikura T, Majima T, Seki S, Chochi K, et al. (2001) Preoperative serum interleukin-18 level as a postoperative prognostic marker in patients with gastric carcinoma. Cancer 92: 2050-2055. doi:10.1002/1097-0142(20011015)92:8. PubMed: 11596019.
38. Thong-Ngam D, Tangkijvanich P, Lerknimitr R, Mahachai V, Theamboonlers A, et al. (2006) Diagnostic role of serum interleukin-18 in gastric cancer patients. World J Gastroenterol 12: 4473-4477. PubMed: 16874857.
39. Bushley AW, Ferrell R, McDuffie K, Terada KY, Carney ME, et al. (2004) Polymorphisms of interleukin (IL)-1alpha, IL-1beta, IL-6, IL-10, and IL-18 and the risk of ovarian cancer. Gynecol Oncol 95: 672-679. doi:10.1016/j.ygyno.2004.08.024. PubMed: 15581980.
40. Jaiswal PK, Singh V, Srivastava P, Mittal RD, (2013) Association of IL-12, IL-18 variants and serum IL-18 with bladder cancer susceptibility in North Indian population. Gene 519: 128-134. doi:10.1016/j.gene.2013.01.025. PubMed: 23403235.
41. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K, (2002) A comprehensive review of genetic association studies. Genet Med 4: 45-61. doi:10.1097/00125817-200203000-00002. PubMed: 11882781.
42. Dick DM, (2011) Gene-environment interaction in psychological traits and disorders. Annu Rev Clin Psychol 7: 383-409. doi:10.1146/annurev-clinpsy-032210-104518. PubMed: 21219196.